Cargando…
Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794444/ https://www.ncbi.nlm.nih.gov/pubmed/17094794 http://dx.doi.org/10.1186/cc5071 |
_version_ | 1782132178001330176 |
---|---|
author | Gupta, Sanjay Milbrandt, Eric B Chelluri, Lakshmipathi |
author_facet | Gupta, Sanjay Milbrandt, Eric B Chelluri, Lakshmipathi |
author_sort | Gupta, Sanjay |
collection | PubMed |
description | |
format | Text |
id | pubmed-1794444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-17944442007-02-08 Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death Gupta, Sanjay Milbrandt, Eric B Chelluri, Lakshmipathi Crit Care Journal Club Critique BioMed Central 2006 2006-11-03 /pmc/articles/PMC1794444/ /pubmed/17094794 http://dx.doi.org/10.1186/cc5071 Text en Copyright © 2006 BioMed Central Ltd |
spellingShingle | Journal Club Critique Gupta, Sanjay Milbrandt, Eric B Chelluri, Lakshmipathi Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
title | Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
title_full | Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
title_fullStr | Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
title_full_unstemmed | Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
title_short | Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
title_sort | drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death |
topic | Journal Club Critique |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794444/ https://www.ncbi.nlm.nih.gov/pubmed/17094794 http://dx.doi.org/10.1186/cc5071 |
work_keys_str_mv | AT guptasanjay drotrecoginalfaactivatedshouldnotbeusedinpatientswithseveresepsisandlowriskfordeath AT milbrandtericb drotrecoginalfaactivatedshouldnotbeusedinpatientswithseveresepsisandlowriskfordeath AT chellurilakshmipathi drotrecoginalfaactivatedshouldnotbeusedinpatientswithseveresepsisandlowriskfordeath |